Skip to Content


In the US, Streptokinase (streptokinase systemic) is a member of the drug class thrombolytics and is used to treat Arterial Thrombosis, Deep Vein Thrombosis, Heart Attack, Pulmonary Embolism and Thrombotic/Thromboembolic Disorder.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Anticoagulant agent: Fibrinolytic enzyme

Chemical Name

Co-enzyme obtained from cultures of various strains of Streptococcus haemolyticus

Foreign Names

  • Streptokinasum (Latin)
  • Streptokinase (German)
  • Streptokinase (French)
  • Estreptoquinasa (Spanish)

Generic Names

  • Streptochinasi (OS: DCIT)
  • Streptokinase (OS: BAN, DCF)
  • Streptokinase (PH: Ph. Eur. 4)
  • Streptokinase Bulk Solution (PH: BP 2010, Ph. Eur. 8)
  • Streptokinase Concentrated Solution (PH: BP 2016)
  • Streptokinasi soultio ad praeparationem (PH: Ph. Eur. 8)
  • Streptokinasum (PH: Ph. Eur. 4)

Brand Names

  • Akinase
    Akhai, Pakistan
  • Amikase
    Neomedix, Pakistan
  • Biofactor Streptokinase
    Beacon Pharmaceuticals, United Kingdom; LENIS, Slovenia
  • Biostrepta (Streptokinase and Streptodornase)
    Biomed Warszawa, Poland
  • Britton Streptokinase
    Dae Han New Pharma, Philippines
  • Durakinase
    Dong Kook, Bangladesh
  • Estreptoquinasa
    Sicma, Colombia
  • Estreptoquinasa Streptase
    CSL Behring, Argentina
  • Estreptoquinasa Streptonase
    Blaú, Colombia
  • Icikinase
    AHPL, India
  • Kabikinase
    Kabi, Egypt; Pharmacia & Upjohn Pty, Lithuania
  • Lifokinase
    Shasun, India
  • Myokinase
    Biocon, India
  • Prokinase
    Emcure, India
  • Reptoquin
    Alvartis Pharma, Mexico
  • Rotakinase
    Sedico, Georgia
  • Sedonase
    Sedico, Egypt
  • Sikaitong
    Wanbang Biochemical Pharmaceutical Company, China
  • Stapo
    Health Biotech, India
  • STPase
    Cadila, India
  • ST-Pase
    Cadila Pharma, Philippines
  • Streptase
    Boehringer Ingelheim, Egypt; CSL, Australia; CSL, Malaysia; CSL Behring, Bosnia & Herzegowina; CSL Behring, Brazil; CSL Behring, China; CSL Behring, Germany; CSL Behring, Denmark; CSL Behring, Spain; CSL Behring, France; CSL Behring, Hong Kong; CSL Behring, Hungary; CSL Behring, Israel; CSL Behring, Netherlands; CSL Behring, Poland; CSL Behring, Portugal; CSL Behring, Serbia; CSL Behring, Sweden; CSL Behring, Taiwan; CSL Behring UK, United Kingdom; Dexa Medica/CSL Behring, Indonesia; Farma-Tek, Turkey; Hoechst, Greece; Hoechst, Lebanon; Mirren, South Africa; PharmaSwiss, Croatia (Hrvatska); Sanofi Aventis, India; Sanofi-Aventis, Bangladesh; ZLB Behring, Bulgaria
  • Streptokin
    Reyon Pharma, Philippines
  • Streptokinase Beacon
    Beacon Pharmaceuticals, United Kingdom
  • Streptokinase Braun
    B. Braun, Lithuania
  • Thromboflux
    Bharat Serums and Vaccines, Thailand; BSVL, Myanmar; Laboratorios Biosano, Chile
  • Unitinase
    Meizler, Brazil
  • Xintong
    Guoda Pharmaceutical, China


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.